Dividend compounder review

TXG

10X Genomics Inc · NASDAQ · US

Healthcare · Health Information Services

Chart Factor Intelligence Back to Screener
Score31.50/100
Confidence78.00/100
DecisionInsufficient Data
RatingAvoid
Scoring

Quality breakdown

Dividend Reliability 0.0 / 25 Payment history, cuts, growth, and regularity.
Dividend Sustainability 14.0 / 20 Payout, free cash flow, dividend cover, and debt.
Business Quality 11.5 / 25 Scale, cash generation, growth, margins, and returns.
Valuation Discipline 1.0 / 15 Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend 5.0 / 15 Trend line, long return history, and drawdown control.
Metrics

Dividend and business context

Dividend Years0
Dividend Yield0.00%
Payout Ratio0.0%
Dividend Cut 5YNo
Net Income$-43.5M
Free Cash Flow$130.1M
FCF Covers DividendUnknown
Debt / Equity9.99
P/E-
Revenue Growth 5Y16.6%
Net Margin-3.5%
ROE-3.0%
Price vs Trend37.3%
3Y Return-47.2%
5Y Return-84.8%
CurrencyUSD
Warnings

Review flags

No usable dividend history found.
Debt to equity is elevated at 9.99.
Dividend diary

Activity record

TXG dividend review warning Warning · Warning

Debt to equity is elevated at 9.99.